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LYSOZYME PLAYS A DUAL ROLE AGAINST THE DIMORPHIC
FUNGUS Paracoccidioides brasiliensis
Damaris LOPERA(1), Beatriz H. ARISTIZABAL(1,2), Angela RESTREPO(1), Luz Elena CANO(1,3) & Ángel GONZÁLEZ(1,3)
SUMMARY
In order to determine the role of lysozyme, an antimicrobial peptide belonging to the innate immune system, against the
dimorphic fungus Paracoccidioides brasiliensis, co-cultures of the MH-S murine alveolar macrophages cell line with P. brasiliensis
conidia were done; assays to evaluate the effect of physiological and inflammatory concentrations of lysozyme directly on the
fungus life cycle were also undertaken. We observed that TNF-α-activated macrophages significantly inhibited the conidia to
yeast transition (p = 0.0043) and exerted an important fungicidal effect (p = 0.0044), killing 27% more fungal propagules in
comparison with controls. Nonetheless, after adding a selective inhibitor of lysozyme, the fungicidal effect was reverted. When P.
brasiliensis propagules were exposed directly to different concentrations of lysozyme, a dual effect was observed. Physiologic
concentrations of the enzyme facilitated the conidia-to-yeast transition process (p < 0.05). On the contrary, inflammatory
concentrations impaired the normal temperature-dependant fungal transition (p < 0.0001). When yeast cells were exposed to
lysozyme, irrespective of concentration, the multiple-budding ability was badly impaired (p < 0.0001). In addition, ultra-structural
changes such as subcellular degradation, fusion of lipid vacuoles, lamellar structures and interruption of the fibrilar layer were
observed in lysozyme exposed conidia. These results suggest that lysozyme appears to exert a dual role as part of the anti-P.
brasiliensis defense mechanisms.
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INTRODUCTION
In respiratory tract secretions, lysozyme is the most abundant
antimicrobial peptide, and its local levels increase tenfold during
inflammation31. The bactericidal properties of lysozyme are primarily
ascribed to its enzymic activity, resulting in hydrolysis of β-linkage
between the N-acetylglucosamine and N-acetylmuramic of the bacterial
peptidoglycan causing cell lysis. However, an increasing body of
evidence supports the existence of non-enzymatic and/or non-lytic
modes of action still not well characterized11,20. The antimicrobial action
of lysozyme contributes to the innate host defense and acts in concert
with the mechanical and phagocytic clearance mechanisms of the host
interacting also with other cationic proteins7. Lysozyme is present in
the phagocytic cells’ granules of neutrophils, as well as in macrophages,
monocytes and epithelial cells. After its discovery by Alexander
Fleming in 1922, the enzymatic action of lysozyme has been extensively
characterized; however, its role in the host-parasite interaction has been
studied more intensely in bacteria than in fungi.
Although lysozyme is constitutively expressed, providing an ever
present defense, pro-inflammatory cytokines, such as tumor necrosis
factor alpha (TNF-α), dramatically increase lysozyme levels. TNF-α
is a pleiotropic cytokine capable of increasing the respiratory burst
stimulating lysozyme overproduction by human macrophages25,30.
Paracoccidioidomycosis (PCM) is one of the most important
endemic mycosis in Latin America. This mycosis affects primarily the
lung and is frequently followed by dissemination to mucosa, skin,
adrenals and other organs and systems2,27. The natural infection is
acquired by inhalation of Paracoccidioides brasiliensis conidia,
propagules that convert into the invasive yeast form once in the lungs27.
In a murine model of PCM, it was observed that resistant mice
(AS/n) infected with P. brasiliensis yeast cells were able to control the
infection when compared with susceptible mice (B10A); additionally,
high levels of TNF-α were found in the former indicating an important
role of this cytokine in host’s defense22.
It is also known that the mononuclear phagocytic system plays a
fundamental role in resistance to P. brasiliensis17. On the same token,
macrophages activated with interferon gamma (IFN-γ) or TNF-α have
antifungal properties against P. brasiliensis that can be dependent or
independent of nitric oxide production, respectively12,13. Although TNF-
α is clearly required, the mechanism by which this cytokine contributes
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to fungus control is not fully understood. In this study, we attempted
to determine if lysozyme participates in the fungicidal/fungistatic
mechanism against P. brasiliensis conidia or if this enzyme would
affect either the conidia-to-yeast transition or the multi-budding process
of this pathogenic fungus.
MATERIALS AND METHODS
Reagents: Hen egg white lysozyme, immunochemicals and all
reagents employed in this study were obtained from Sigma Chemical
Co. (St Louis, USA), unless specified.
Production and collection of P. brasiliensis conidia: P. brasiliensis
strain deposited in the American Type Culture Collection (ATCC No.
60855) and originally isolated from a Colombian patient was used
throughout this study28.
The fungus was maintained at 18 ºC in its mycelial form by successive
transfers on synthetic McVeigh-Morton (SMV) medium26. Growth was
then transferred to an Erlenmeyer with liquid SMV and incubated for
10-15 days (18 ºC) with constant shaking at 150 rpm (Model G-2 gyratory
shaker, New Brunswick Scientific, Co. New Brunswick, N.J.). After this
time, the growth was collected, homogenized in a blender (Eberbach
container assembly semi-micro press with fit cover) for 15-20 seconds
in four intervals of four seconds each, and plated in Petri dishes containing
a media that stimulates sporulation, namely, water agar medium and
dextrose salts agar3,28. The culture dishes were incubated at 18 ºC for
periods of 3-5 months and inspected periodically for the presence of
contaminating bacteria or mold growth.
Culture dishes were washed with 0.85% saline solution plus 0.01%
of Tween-20; this suspension was then shaken at 250 rpm for 45 min at
18 ºC in Erlenmeyer flask containing glass beads. The homogenized
suspension was sonicated twice for 15 seconds (7Hz) at 4 ºC with one
minute intervals (Sonicator model 200, Branson Ultrasonic Co,
Danbury,CT)
The conidia were separated from the mycelium fragments through
Percoll gradients16 and finally, their viability was determined using
the fluorescein diacetate-ethidium bromide fluorescence method4.
All procedures leading with conidia were carried out with extreme
precautions and were manipulated in biological safety cabinets class
IIA.
Production and collection of P. brasiliensis yeast cells: Yeast
cells cultures were maintained by periodic transfers each four days to
Sabouraud dextrose medium, supplemented with 0.2% asparagine
(Sigma) and 0.01% thiamine (Sigma) at 36 ºC. The growth was washed
with 2 mL of phosphate buffer and adjusted to 25 mL of this buffer. In
order to separate the yeast’s buds from the mother cell (≤ 2 buds); the
suspension was sonicated twice for 20 seconds (7Hz) at 4 ºC with one
minute intervals. After separation, the yeasts were counted in a
hemocytometer. The sonication procedure did not alter the yeast’s
viability (standardized procedure in our laboratory).
Alveolar Macrophages: The MH-S murine alveolar macrophages
cell line, originally collected from BALB/c mice and deposited in the
European Collection of Cell Cultures (EACC, No. 95090612), were
cultured at 37 ºC, 5% CO
2
 in RPMI-1640 medium supplemented with
15% of foetal bovine serum, 2 mM glutamine and 0.05 mM 2-β-
mercaptoethanol21.
Monolayer treatments: Confluent MH-S cell monolayers were
harvested, counted in a hemocytometer and their viability determined
by trypan blue exclusion. Cellular suspension was adjusted at 6.25
x104 viable cells/mL and 0.4 mL of this suspension was deposited in
each eight-well LabTekMR chambers slides (Cat number 177402;
Nalgene Nunc International, Naperville, IL).
Macrophages were treated with 10 ng/mL of TNF-α (Cat number
T-7539, Sigma) 24 h before infection12 and/or with a competitive
inhibitor of the enzymatic activity of lysozyme, N, N’, N”-
triacetylglucosamine (NAG3), also referred as N, N’, N”-
triacetylchitotriose (Cat number T-2144 St, Sigma)1,19. In order to inhibit
the constitutively lysozyme production, the inhibitor was added
simultaneously with TNF-α before infection. The final concentration
of this trisaccharide was 140 µM, which represents four molecules of
the inhibitor per each one of lysozyme. In addition, non-infected and
non-treated macrophages were also studied and used as controls.
Infection of macrophages: Conidia were suspended in RPMI
containing 30% (vol/vol) fresh mouse serum from BALB/c mice.
Conidial suspensions were incubated at 37 ºC for 20 min for
opsonization to take place5. Monolayer macrophages were inoculated
with 0.02 mL of the conidial suspension, which gave a conidium-to-




Determination of the conidia -to-yeast transition process: Slides
removed from this chambers were fixed with cold absolute methanol,
air dried, and stained with silver methenamine (Grocot’s stain) to
determine the presence of intracellular fungal propagules12. The
monolayers were observed with light microscopy (40X) and the number
of intracellular fungal propagules was counted, distinguishing between
conidia (non-transformed) and yeast cells (transformed). More than
200 intracellular propagules were counted and the percent of
transformation was calculated as number of intracellular yeast cells/
200 intracellular fungal cells × 100.
Colony forming units (CFU): Other chamber wells were used to
evaluate the CFU’s number. The monolayers were lysed with 200 µL
of distilled water for 30 min at 37 ºC and the suspension was harvested
and adjusted to a final volume of 1 mL; 350 µL of the latter suspension
were plated in agar plates (60 per 15 mm of diameter) with BHI plus
5% of glucose (Cat Number G5400, Sigma), 300 µM EDTA and 4%
horse serum (Gibco, Grand Island, NY, USA; Cat Number 16055-122)18.
The inoculated agar dishes were incubated at 36 ºC for 15 days, and
colonies per plate were counted after eight to 10 days of incubation.
Fungal cultures in presence of lysozyme: A stock solution of
lysozyme was dissolved in sterile distilled water at a concentration of
16 mg mL-1 and sterilized by passage through a 0.22 µm Millipore
filter MFS 25 (Millipore Co., Bedford, MA, USA).
Conidial suspension at a final concentration of 50,000 conidia per
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mL were transferred to each of six tubes containing 1.0 mL of filtered
BHI supplemented with 1% glucose (Cat Number G5400, Sigma),
0.01% thiamine and 0.02% L-cystine (Cat number C-8755, Sigma).
Each tube received a different lysozyme volume, reaching final
concentrations of 0, 50, 100 µg/mL (physiological concentrations) and
200, 400 and 800 µg/mL (inflammatory concentrations)24. Aliquots of
200 µL were plated by triplicate in 96 wells microplates (Nunclon
Surface, Nunc Brand) and incubated at 36 °C ± 0.5 ºC for 96 hours.
Dimorphic transition and budding changes determination: To
determine if lysozyme induced morphological changes in P. brasiliensis
propagules, we evaluated the capacity of the conidia to convert into
yeast, and also yeast budding.
After 24, 48, 72, and 96h of incubation, the kinetics of conidium-
to-yeast transition was determined. Morphological evaluation was made
in an inverted microscope (Lietz Diavert 903, Germany). The number
of single or multi-budding yeast cells was counted in each well to
evaluate the transition process.
In order to evaluate lysozyme effects on the budding process, yeast
cells obtained after the sonication process were exposed to the same
concentrations of lysozyme and plated to a final concentration of 1 x
103 yeasts per well. After 24, 48, and 72 hours post-incubation the
number of multi-budding yeast cells were counted.
Ultrastructural changes determined by transmission electron
microscopy: Conidia treated with lysozyme at concentrations of
50 µg/mL and 800 µg/mL were harvested by centrifugation after 96h
of incubation, washed once in phosphate buffer and fixed in 3%
glutaraldehyde in 0.1M phosphate buffer (pH 7.2) overnight. Samples
were processed according to standard protocols9. In brief, the fixed
samples were treated with 2% OsO4 at room temperature for one hour,
dehydrated slowly with ethanol and embedded in Epon resin. Thin-
sections were observed in a Zeiss EM electron microscope.
Statistical analyses: Results are expressed as the mean ± standard
deviation for at least three experiments by duplicate (n = 6).
Comparisons between groups were analyzed by the Student t test using
the GraphPad Prism program, version 4.0 (California, USA). A value
of p < 0.05 was considered statistically significant.
RESULTS
Intracellular transition of P. brasiliensis conidia after lysozyme
inhibition: As shown in Fig. 1A and 1B, 96h after infection of the
macrophages with P. brasiliensis conidia, fungal propagules appeared
internalized by phagocytes. In non-activated and non-lysozyme treated
macrophages (control group), we observed that approximately 50% of
these propagules had undergone intracellular transition. The addition
of TNF-α resulted in significant (p = 0.0043) inhibition of the conidium-
to-yeast transition process in comparison with the control group (Fig.
1C). Nonetheless, this effect was reverted in the presence of the
lysozyme inhibitor (p = 0.0022), a reagent that also inhibited the
transition process in the non-activated macrophages exposed to the
same inhibitor, in a way similar to that TNF-α.
Lysozyme participation in the fungicidal/fungistatic effect
exerted by TNF-α-activated macrophages infected with P.
brasiliensis conidia: The ability of the alveolar macrophages to destroy
fungal propagules was evaluated by determining CFU’s number. As
shown in Fig. 1D, only macrophages activated with TNF-α exerted a
Fig. 1 - P. brasiliensis intracellular transition and CFU of conidia after lysozyme inhibition
in normal or TNF-α activated Møs. A) Morphology of intracellular P. brasiliensis conidia,
and B) yeast cells observed after 96 h of co-culture with alveolar macrophages (Magnifications
1000X). C) Intracellular transition of P. brasiliensis conidia, after lysozyme inhibition in
activated or non-activated macrophages with TNF-α for 96 h at 37 ºC (n = 6). Bars show the
mean ± SEM. *p < 0.01 between the control group (non-activated Møs infected with
P.brasiliensis conidia) and the group of TNF-α-activated Møs. † p < 0.01 between TNF-α-
activated Møs and Møs with the same treatment plus lysozyme inhibitor. D) Colony forming
units (CFUs) recovered from alveolar Møs activated or non-activated with TNF-α, infected
with P. brasiliensis conidia and treated with lysozyme inhibitor after incubation for 96 h at
37 ºC (n = 18). The bars show the mean ± SEM. * p = 0.0044 between TNF-α-activated Møs
and control group (Mø+C). † p = 0.0054 between TNF-α-activated Møs and Møs with the
same treatment plus lysozyme inhibitor.
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fungicidal effect on P. brasiliensis conidia (p = 0.0044). This group of
phagocytes destroyed 27% more propagules than the non-activated
macrophages, an effect that was reverted in the presence of the lysozyme
inhibitor (p = 0.0054).
Effect of lysozyme on the fungal transition: Fig. 2A and 2B show
the effect of different concentrations of lysozyme in the transition of
P. brasiliensis conidia, and the capacity of this new yeast cells to bud.
The susceptibility of conidia was dependent on lysozyme concentration.
Physiological concentrations of the enzyme (50 and 100 µg/mL) (Fig.
2A) facilitated the conidia-to-yeast transition process, p < 0.001 and
p < 0.05, respectively. On the contrary, inflammatory concentrations
of lysozyme (400 and 800 µg/mL) impaired fungal transition (p <
0.001), as well as its budding ability (p < 0.001) (Fig. 2A and 2B).
Effect of lysozyme on the ability of yeast to bud: In order to confirm
the effect of lysozyme on the multi-budding capacity described above,
the effect of lysozyme directly on the tissue yeast form was evaluated.
As observed in Fig. 2C, yeasts incubated for 72 hours in the presence of
different lysozyme concentrations presented a smaller number of
blastoconidia in all groups exposed to this enzyme, in contrast to control
yeast (no lysozyme) which exhibited multiple budding. This inhibition
became apparent from the first 24h when only 25% of the yeasts exposed
to the different concentrations of lysozyme were able to begin their
budding, in contrast with 45% observed in the control yeast. Similar
findings were observed after 48 and 72h post-incubation being more
evident in the latter. After 72h post-incubation multiple-budding increased
to 72% in the control group in contrast to yeasts exposed to lysozyme
which rose only less than 50%. Concentrations of lysozyme were not
statistically significant different from each other.
Ultrastructural changes: Transmission electron micrograph of
untreated P. brasiliensis conidia is presented in Fig. 3A. Conidia show
their characteristic oval or pear shape, homogenous intracytoplasmic
lipid bodies and well delimited cell wall. These propagules had a clear
thin layer near the plasma membrane that delimited the periplasmic
space. The cellular wall was surrounded by a fibrillar material that, in
some cases, appeared discontinuous in the wall; none of untreated P.
brasiliensis conidia studied shown an apparently change on their
ultrastructure.
Nonetheless, propagules exposed to physiologic and inflammatory
concentration of lysozyme (50 µg/mL and 800 µg/mL, respectively)
showed similar changes. The most evident ultrastructural changes were
observed in the cytoplasm where fusion of lipid bodies and formation
of lamellar structures as a product of subcellular degradation were
recorded (Fig. 3B and 3D). In some cells it was evident cytoplasm
reduction (Fig. 3D). Although the interruption of fibrillar layer was
also observed in control cells, it was more evident in conidia exposed
to lysozyme (Fig. 3C).
DISCUSSION
These results reveal for the first time that lysozyme probably
participates in the restriction and control of the pathogenic fungus P.
brasiliensis cooperating with TNF-α-activated macrophages in their
fungicidal/fungistatic mechanisms exerted against the infective
propagules.
TNF-α-activated macrophages impaired both the transition process
and the viability of conidia, effects that could be reverted in the presence
of the lysozyme inhibitor, suggesting that this enzyme contributes to
Fig. 2 - Effects of different concentrations of lysozyme on P. brasiliensis conidial transition
process and the budding capacity of yeasts. A) Number of conidia per field that underwent
dimorphic transition to yeast cells. B) Transition according to the observed propagules,
individual yeasts and multiple budding yeast cells. The bars show the mean ± SEM. **p <
0.001 *p < 0.05 when compared to the control (cultures without lysozyme). C) Kinetic of P.
brasiliensis budding after 24, 48 and 72 hours of yeast exposure to lysozyme. Bars show the
mean ± SEM of percentage of multiple budding yeast of three experiments run in duplicate
(n = 6). ***p < 0.0001 when compared yeast cells without lysozyme (control) and yeasts in
the presence of different concentration of the enzyme.
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the defense mechanisms exerted by the macrophages activated with
TNF-α.
We observed that when the lysozyme inhibitor was added to non-
activated macrophages the transition process was impaired.
Nonetheless, the viability of the fungus remained unaffected as shown
by the CFU. Since we did not find a direct negative effect of the
lysozyme inhibitor on P. brasiliensis growth (data not shown), new
approaches are needed to identify the effect observed on the intracellular
transition process.
TNF-α is involved in multiple steps in the antifungal and
inflammatory responses against P. brasiliensis. This cytokine activates
macrophages and is required for the sustained recruitment of
inflammatory cells into granulomatous lesions22,32. In addition, previous
studies done by our group have demonstrated that TNF-α-activated
macrophages exert an antifungal effect independent of nitric oxide
production12. According with the above results, the present study
suggests that lysozyme probably contributes to the mechanisms exerted
by TNF-α-activated macrophages.
In addition, in this study we observed that inflammatory
concentrations of lysozyme were capable of inhibiting both conidia-
to-yeast transition and budding processes.
However, a contrary effect was noticed when physiological
concentration of lysozyme resulted in the increase of the transitional
process. This effect should be explored further in order to understand
the differential behavior according to lysozyme concentrations.
On the other hand, in vitro assays have shown that the budding
process was inhibited by lysozyme even at concentrations lower than
50 µg/mL, suggesting that minimal amounts of this enzyme are
sufficient to control the development of the fungus in its tissue form.
The absence of a dose-dependent effect on budding suggests that
inflammatory (higher) concentrations of this antimicrobial peptide
would not be more effective against the fungus.
CANTOR et al.6, using an animal model of emphysema showed
that when hamsters were exposed to aerosolized lysozyme, this enzyme
enhanced elastolysis, suggesting that deposition of lysozyme in the
lung’s extracellular matrix may enhance the progression of pulmonary
emphysema. Studies performed in our laboratory have shown that in
mice infected with P. brasiliensis conidia marked lysozyme expression
is induced in the lungs during first four days post-infection (unpublished
data). In addition, recently we observed marked elastolysis during this
early inflammatory infiltration14.
Additionally, in the TEM studies the most evident ultrastructural
changes observed in lysozyme-treated conidia occurred in the cytoplasm
where fusion of lipid bodies and lamellar structures were apparent.
The mechanism responsible for these changes is not well understood
and it would be difficult to attribute such effect to the sole enzymatic
activity. It is known that the target of lysozyme is the polysaccharide
exposed on the cell wall; however, two additional hypotheses suggested
that a variety of cationic peptides (including lysozyme) might render
bacteria non-viable by activating their autolytic wall enzymes leading
to bacteriolysis11; other possibility to be considered is that lysozyme
has antibacterial activities independent of its enzymatic action, probably
due to its positive charge15.
It is important to emphasize that results obtained from in vitro
studies are not necessarily predictive of their activity in vivo, because
this enzyme may be increased by certain cofactors such as lactoferrin,
hydrogen peroxide, defensins and cathelisicidins7,10,33. Thus, it is
possible that the effect observed in vitro by lysozyme could be
potentiated in vivo by these other reactants; however, more studies to
confirm the participation of these cofactors are needed.
Studies on the antifungal action of lysozyme have focused on
Candida albicans. NISHIYAMA et al.24 showed that lysozyme inhibited
the separation of apparently mature C. albicans yeast cells from each
other, and recorded also accumulation of wall-like material in the
periplasmic space indicating that cell-wall components may be possible
targets for this enzyme. Additionally, they found a synergistic action
between lysozyme and lanoconazole, an antifungal drug.
In other study, WU et al.34 showed that lysozyme had a dual action
on C. albicans, killing the organism at higher concentrations and
Fig. 3 - Ultrastructural changes on conidia exposed to lysozyme by transmission electron
microscopy. A) Untreated conidia (control) display homogenous intracytoplasmic lipid bodies
(L), arrow head indicates the periplasmic space and arrow indicates the fibrillar layer that
delimits the cellular wall (Magnification 22,000X). B-D) Conidia exposed to lysozyme; B)
conidia displays lamellar structure formation (arrow head) inside of a big lipid body (LB). In
the cytoplasm, bodies of different sizes and densities that don’t show sub-cellular definition
can be observed. C) Conidia displaying normal cytoplasmic appearance with homogeneous
lipid bodies and great amount of glycogen that occupies most of the cytoplasm (G). Observe
that the cellular wall lacks the fibrillar layer; D) conidium exhibits a giant lipid body occupying
great part of the cytoplasm (LB); in addition, non continuous membrane structures and a
residual appearance in the cytoplasm can also be observed; arrow indicates protrusions of
the cell wall. Bar 1.0 µm (Magnification 22,000X).
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modulating the production of aspartyl proteinases, a putative virulence
factor of C. albicans. SAMARANAYAKE et al.29, reported that although
generally the Candida species such as C. glabrata, C. albicans, C.
tropicalis and C. krusei, were susceptible to lysozyme, differences in
their susceptibility were noted among the different isolates within the
same species. Fungi such as Aspergillus fumigatus, Rhizopus orizae8
and Histoplasma capsulatum23 also showed certain susceptibility to
lysozyme, compound that mediated a fungistatic mechanism.
In this study, we observed that lysozyme induced ultrastructural
and morphological changes in P. brasiliensis propagules; nonetheless,
more studies are necessary to determine the mechanisms involved in
the changes brought about by this enzyme on the fungal structures.
Finally, the knowledge gained concerning the molecules implied
in the microbicidal activity generated by activated macrophages would
allow identification of key molecules that may contribute to improve
fungal control. Therefore, we consider that lysozyme could be a target
for further developments aimed at defining its importance in the host
defense against P. brasiliensis infection.
RESUMO
A lisozima desempenha um papel duplo contra o fungo
dimórfico Paracoccidioides brasiliensis
Com a finalidade de determinar o papel da lisozima, um peptídeo
antimicrobiano que pertence ao sistema imune inato, contra o fungo
dimórfico Paracoccidioides brasiliensis, foram feitas co-culturas de
uma linha de macrófagos alveolares murinos (MH-S) com as conídias
do fungo na presença ou não do TNF-α e/ou um inibidor da lisozima;
também foram feitos ensaios que avaliaram o efeito das concentrações
fisiológicas e inflamatórias de lisozima diretamente sobre o ciclo de
vida do fungo. Observamos que os macrófagos ativados com a citoquina
tiveram um efeito significativo na inibição da transição conídia/levedura
(p = 0,0043) e exerceram um efeito fungicida importante (p = 0,0044),
matando mais de 27% das propágulas do fungo em comparação com
os macrófagos não ativados. No entanto, após ser o inibidor seletivo
da lisozima adicionado, o efeito fungicida foi revertido. Quando os
propágulos do fungo foram expostos diretamente a diferentes
concentrações da lisozima, um duplo efeito foi observado. Assim, as
concentrações fisiológicas da enzima facilitaram o processo de transição
conídia-levedura (p < 0,05). Contrariamente, as concentrações
inflamatórias prejudicaram a transição fúngica (p < 0,0001). Quando
as leveduras foram expostas a qualquer concentração de lisozima, sua
capacidade de multi-brotação foi gravemente prejudicada (p < 0,0001).
Além disso, mudanças ultra-estruturais, como a sub degradação, a fusão
dos vacúolos dos lípidos, estruturas lamelares e interrupção da camada
fibrilar foram observadas em conídios expostos à lisozima. Estes
resultados sugerem que a lisozima poderia exercer um duplo papel no
mecanismo antifúngico contra P. brasiliensis.
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